首页> 美国卫生研究院文献>Revista Brasileira de Ortopedia >COMPARATIVE STUDY OF BONE NEOFORMATION USING AUTOLOGOUS GRAFTING AND THREE REPLACEMENTS: BONE DEFECTS IN RATS
【2h】

COMPARATIVE STUDY OF BONE NEOFORMATION USING AUTOLOGOUS GRAFTING AND THREE REPLACEMENTS: BONE DEFECTS IN RATS

机译:自体植骨和三种置换术对骨形成的比较研究:大鼠的骨缺损

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective: Compare the percentage of bone neoformation promoted by autologous bone grafting and three kinds of replacement materials with different characteristics in rats' femoral holes. Methods: Two holes measuring 5.4×2.7mm, were produced on each femur (right and left) of 14 isogenic Wistar rats. Each of the four defects produced was filled by autologous bone or by one of three tested materials-hydroxyapatite (HA), Genphos® (HA+ β-TCP) and GenMix® (a combined bovine bone graft). In the end of the 6-week (n = 6) and 12-week (n = 8) periods, the animals were sacrificed. The sections (stained with Picro-Sirius) were assessed by optical microscopy and specific software. Results: The groups with autologous bone were shown to be significantly superior to the others at both assessed times, showing a mean bone formation rate ± SD of 90.6 ± 10.8% in six weeks, and 98 ± 9.2% in 12 weeks (p > 0.0001 for both assessed times). In six weeks, the results for the other groups were the following: Genphos®, 46 ± 7.1%; HA, 43.1 ± 8.4%; and GenMix®, 57.3 ± 4.5%. In 12 weeks: Genphos®, 47.8 ± 11.1%; HA, 39.9 ± 5.4%; GenMix®, 59.7 ± 4.8%, significant (p = 0.007). Conclusions: In both assessed times, the three bone replacement materials tested in the study showed to be inferior to autologous bone graft for bone neoformation percentage.
机译:目的:比较自体植骨和三种不同特性的股骨替代材料在大鼠股骨孔中促进骨形成的百分比。方法:在14只同基因Wistar大鼠的每个股骨(左右)上分别开出两个5.4×2.7mm的孔。产生的四个缺损中的每一个都由自体骨或以下三种测试材料之一填充:羟基磷灰石(HA),Genphos ®(HA +β-TCP)和GenMix ®(组合的牛骨移植物)。在6周(n = 6)和12周(n = 8)结束时,处死动物。切片(用Picro-Sirius染色)通过光学显微镜和专用软件进行评估。结果:显示自体骨组在两个评估时间均显着优于其他组,平均骨形成率在六周内为90.6±10.8%,在十二周内为98±9.2%(p> 0.0001)对于两个评估时间)。在六周内,其他组的结果如下:Genphos ®,46±7.1%; HA,43.1±8.4%;和GenMix ®,为57.3±4.5%。 12周内:Genphos ®,47.8±11.1%; HA,39.9±5.4%; GenMix ®,59.7±4.8%,显着(p = 0.007)。结论:在两个评估时间中,研究中测试的三种骨替代材料的骨新形成率均低于自体骨移植。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号